Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
24%

OVERLAP
BY WEIGHT
17

# OF OVERLAPPING
HOLDINGS
HRTS
43
HOLDINGS
40%
ALSO IN WDNA
WDNA
85
HOLDINGS
20%
ALSO IN HRTS
SECTOR DRIFT (HRTS minus WDNA)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in HRTS
Weight
in WDNA
Overlap
ELI LILLY & CO 10.4% 2.3% 2.3%
BRIDGEBIO PHARMA, INC. 2.2% 4.0% 2.2%
NOVARTIS AG 2.9% 1.9% 1.9%
GILEAD SCIENCES INC 3.3% 1.9% 1.9%
IONIS PHARMACEUTICALS, INC. 1.8% 2.1% 1.8%
HRTS Overweight Relative to WDNA
ELI LILLY & CO 8.1%
ROCHE HOLDINGS LTD-SPONS ADR 4.7%
UNITEDHEALTH GROUP INC 4.4%
ASTRAZENECA PLC 4.2%
ABBOTT LABORATORIES 3.7%
BOSTON SCIENTIFIC CORP 3.1%
MEDTRONIC PLC 3.0%
ABBVIE INC 2.9%
NOVO NORDISK A/S-B 2.5%
THERMO FISHER SCIENTIFIC INC 2.3%
HRTS Underweight Relative to WDNA
NATERA INC -4.4%
BLUEPRINT MEDICINES CORP. -3.8%
NOVOZYMES A/S-B SHARES -3.2%
STOKE THERAPEUTICS, INC. -2.3%
TWIST BIOSCIENCE CORP. -2.2%
UNITED THERAPEUTICS CORP -2.2%
AGIOS PHARMACEUTICALS INC -2.1%
VERACYTE INC -2.1%
BRIDGEBIO PHARMA, INC. -1.8%
VERICEL CORPORATION -1.8%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY